Econopred and Gabapentin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Econopred (prednisolone acetate) and Gabapentin (gabapentin). Common drug interactions include erythema among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Econopred and Gabapentin. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Econopred?

Econopred has active ingredients of prednisolone acetate. eHealthMe is studying from 179 Econopred users. Check the latest studies of Econopred.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in peripheral neuropathy. eHealthMe is studying from 322,987 Gabapentin users. Check the latest studies of Gabapentin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 16, 2026

28 people who take Econopred and Gabapentin together, and have interactions are studied.

Econopred and Gabapentin drug interactions.

What are the common drug interactions of Econopred and Gabapentin, by gender? *:

female:

  1. Erythema (redness of the skin)
  2. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  3. Hyperlipidaemia (presence of excess lipids in the blood)
  4. Lung neoplasm (tumour of lung)
  5. Oedema peripheral (superficial swelling)
  6. Vitamin d deficiency
  7. Anaemia (lack of blood)
  8. Arthralgia (joint pain)
  9. Depressed mood
  10. Diarrhoea

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Stress
  4. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  5. Abdominal pain
  6. Nausea (feeling of having an urge to vomit)
  7. Vomiting
  8. Death
  9. Emotional distress
  10. Fear

What are the common drug interactions of Econopred and Gabapentin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Decreased interest
  2. Dizziness
  3. Dyspnoea (difficult or laboured respiration)
  4. General physical health deterioration (weak health status)
  5. Myalgia (muscle pain)
  6. Osteonecrosis of jaw (death of bone of jaw)
  7. Syncope (loss of consciousness with an inability to maintain postural tone)
  8. Toothache (tooth pain)
  9. Back pain
  10. Hepatic lesion

60+:

  1. Anxiety
  2. Death
  3. Stress
  4. Abdominal pain
  5. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  6. Nausea (feeling of having an urge to vomit)
  7. Vomiting
  8. Arthralgia (joint pain)
  9. Asthenia (weakness)
  10. Cataract (clouding of the lens inside the eye)

What are the existing conditions these people have? *

  1. Constipation: 9 people, 32.14%
  2. Pain: 7 people, 25.00%
  3. Nausea (feeling of having an urge to vomit): 7 people, 25.00%
  4. Stress And Anxiety: 2 people, 7.14%
  5. Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously): 2 people, 7.14%
  6. Peripheral Vascular Disorder: 2 people, 7.14%
  7. Metastases To Bone (cancer spreads to bone): 2 people, 7.14%
  8. Irritable Bowel Syndrome: 2 people, 7.14%
  9. Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 7.14%
  10. Hypersensitivity: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Econopred and Gabapentin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Econopred and Gabapentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Econopred:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Gabapentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Econopred and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gabapentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on prednisolone acetate and gabapentin (the active ingredients of Econopred and Gabapentin, respectively), and Econopred and Gabapentin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: